Cochlear Awarded as the Most Trustworthy Healthcare Company Worldwide

Cochlear Awarded the Title of Most Trustworthy Healthcare Company

In honor of World Hearing Day, Cochlear has proudly received the distinction of being the most trustworthy healthcare company in the world, according to Newsweek's 2024 rankings. Recognized for its unwavering commitment to innovation and customer service within the field of implantable hearing solutions, Cochlear has set a standard in the healthcare industry.

The award comes from an independent ranking conducted in collaboration with Statista, a global research firm that evaluated company trustworthiness through extensive surveys. With over 70,000 participants contributing 269,000 evaluations, the results highlight Cochlear's dedication and exceptional reputation in providing quality care for individuals suffering from hearing loss.

Cochlear's Chief Executive Officer, Dig Howitt, expressed pride in this recognition, stating, “At Cochlear, we prioritize our customers and are committed to ensuring their satisfaction throughout their hearing journey. We offer a comprehensive range of services aimed at providing the best care possible for recipients of our devices. Our Connected Care program integrates rehabilitation initiatives which cater to the ongoing support needs of our users, alongside access to a global community of fellow Cochlear recipients.”

The company's mission transcends beyond just manufacturing hearing implants. Cochlear has been actively engaged in raising awareness around hearing loss and advocating for improved access to hearing care. Howitt continued, “This recognition from Newsweek affirms our commitment to making a real difference in the lives of those affected by hearing loss.”

Since its inception, Cochlear has helped over 700,000 people across 180 countries rebuilding their ability to hear and connect with the world. With a workforce of over 5,000 passionate individuals, Cochlear continuously seeks to innovate and address the needs of those living with hearing challenges. The company has invested more than AUD $3 billion in research and development, pushing the boundaries of technology in hearing solutions.

For more information regarding Cochlear and its pioneering products, please visit www.cochlear.com. Co-founded by Professor Graeme Clark, who was inspired to create the first multi-channel cochlear implant after witnessing his father's struggle with hearing loss, Cochlear's journey illustrates the essence of innovation committed to improving lives.

As Cochlear celebrates this remarkable achievement, the recognition emphasizes the importance of trust in healthcare, fostering more accessible and impactful hearing care solutions for people in need. As Cochlear continues to grow, it remains dedicated to its mission of connecting people with life-changing opportunities, underlining the critical role of trustworthy service in the healthcare sector.